Development and validation of HPLC method for determination of benidipine hydrochloride in lipid vesicles formulations
Document Type
Article
Publication Date
1-1-2022
Abstract
In the current study, a novel high-performance liquid chromatographic method is being developed and validated to estimate benidipine hydrochloride in lipid-based pharmaceutical formulations including transfersome, ethosome, and transethosome. The chromatographic separation was accomplished on a ZORBAX Eclipse Plus C18 (4.6mm x 150mm) analytical column with a mobile phase consisting of a mixture of methanol and 50 mM phosphate buffer solution at a ratio of 70:30 (v/v). A standard calibration curve was used to quantitatively determine the medication at a UV wavelength of 237 nm. The limit of detection (LOD) and limit of quantitation (LOQ) were determined to be 0.005µg/ml and 0.015µg/ml, respectively. The relative standard deviation (RSD) of the intra-day and inter-day studies for benidipine hydrochloride was less than 2, and the percentage recovery of benidipine hydrochloride was found to be in the range of 98.57-100.27. The method is specific, linear, accurate, precise, robust, and sensitive for its intended purpose, according to the results of the method validation. To determine the amount of benidipine hydrochloride and the effectiveness of drug entrapment in lipid-based formulated membrane like cell structures namely Transfersomes, Ethosomes, and Transethosomes the current method was successfully applied. © 2022 Cosmos Scholars Publishing House © 2022 AL-Japairai et al.
Keywords
Benidipine hydrochloride, Drug content, Entrapment efficiency, HPLC, Lipid vesicles
Divisions
phartech
Funders
SATU [Grant no. ST079-2021],Universiti Malaya,Universiti Malaysia Pahang [Grant no. RDU220308]
Publication Title
International Journal of Membrane Science and Technology
Volume
9
Issue
2
Publisher
Cosmos Scholars Publishing House